Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets, added clinical bottling and labeling capabilities at its Small Molecules site in Bend, OR. Building upon the recent investment in the early-phase clinical manufacturing facility, the offering now includes new bottling equipment for filling tablets and powder-filled capsules. The additional equipment aims to further support customers in the early stages of development.   The new equipment can detect defects in ta...